Dna adducts, mutations and cancer

Carcinogenesis

Volumn 14, Issue 10, 1993, Pages 2007-2012

  Hemminki, Kari ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; CANCER; CARCINOGENESIS; DNA ADDUCT; GENE MUTATION; HUMAN; HUMAN CELL; HUMAN TISSUE; MOUSE; MUTATION; NONHUMAN; NOTE; PRIORITY JOURNAL;

ANIMAL; CARCINOGENS; DNA; HUMAN; MUTAGENS; MUTATION; NEOPLASMS; NEOPLASMS, EXPERIMENTAL; SUPPORT, NON-U.S. GOV'T;

EID: 0027382208     PISSN: 01433334     EISSN: None     Source Type: Journal    
DOI: 10.1093/carcin/14.10.2007     Document Type: Note

References (67)

1. Perera, F.P. (1988) The significance of DNA and protein adducts in humanbiomonitoring studies. Mutat. Res., 205, 255-269
2. Lawley, P.D. (1989) Mutagens as carcinogens: Development of currentconcepts. Mutat. Res., 213, 3-25
3. ECETOC (1989) DNA and protein adducts: Evaluation of their use in exposuremonitoring and risk assessment. Monograph no. 13, Brussels
4. Harris, C.C. (1991) Chemical and physical carcinogenesis: Advances andperspectives for the 1990s Cancer Res. Suppl., 51, 5023-5044
5. Hemminld, K. (1992) Significance of DNA and protein adducts. In Vainio, H., Magee, P.N. and McMichael, A.J. (eds), Mechanisms of Carcinogenesis inRisk Identification. LARC, Lyon, pp. 525-534
6. HemminId, K., Dipple, A., Shuker, D.E.G., Kadlubar, F.F., Segerbck, D. andBartsch, H. (eds) (1993) DNA Adducts: Identification and BiologicalSignificance. LARC Scientific Publication 125, Lyon, in press
7. Hemminki, K. (1983) Nucleic acid and adducts of chemical carcinogens andmutagens. Arch. Toxicol., 52, 249-285
8. Phillips, D.H. (1983) Fifty years of benzo(a)pyrene. Nature, 303, 468-472
9. Randerath, K., Reddy, M.V. and Gupta, R.C. (1981) 32P-labelling test forDNA damage. Proc. Natl Acad. Sci. USA, 78, 6126-6129
10. Gupta, R.C., Reddy, M.V. and Randerath, K. (1982) 32P-postlabelling analysisof non-radioactive aromatic carcinogen-DNA adducts. Carcinogenesis, 3, 1081-1092
11. Reddy, M.V. and Randerath, K. (1986) Nuclease Pl-mediated enhancement of sensitivity of 32P-postlabelling test for structurally diverse DNA adducts. Carcinogenesis, 7, 1543-1551
12. Poirier, M.C. (1981) Antibodies to carcinogens-DNA adducts. J. Nad CancerInst., 67, 515-519
13. Bartsch, H., Hemminki, K. and O’Neill, I.K. (1988) Methods for Detecting DNADamaging Agents in Humans: Applications in Cancer Epidemiology andPrevention. International Agency for Research on Cancer, Lyon
14. Henuninld, K., Perera, F.P., Phillips, D.H., Randerath, K., Reddy, M.V. andSantella, R.M. (1988) Aromatic DNA adducts in white blood cells of foundryworkers. In Bartsch, H., Hemminki, K., O’Nefll, I. (eds), Methods for DetectingDNA Damaging Agents in Humans: Applications in Cancer Epidemiology andPrevention. IARC Scientific Publication No. 89, Lyon, pp. 190-195
15. Savela, K. and Hemminki, K. (1991) DNA adducts in lymphocytes and granulocytes of smokers and nonsmokers detected by the 32P-postlabellingassay. Carcinogenesis, 12, 503-508
16. van Schooten, F.J., Hillebrand, M.J.X., van Leeuwen, F.E., Lutgerink, J.T., van Zandwijk, N., Jansen, H.M. and Kriek, E. (1990) Polycyclic aromatichydrocarbon-DNA adducts in lung tissue from lung cancer patients.Carcinogenesis, 9, 1677-1681
17. Kadlubar, F.F. (1993) DNA adducts of carcinogenic aromatic amines. InHemminldOC., Dipple, A., Shuker, D.E.G., Kadlubar, F.F., SegerbSck, D. andBartsch, H. (eds), DNA Adducts: Identification and Biological Significance.IARC, Lyon, in press
18. Fanner, P.B., Bailey, E., Naylor, S., Anderson, D., Brooks, A., Cushnir, I., Tamh, J.H., Sepai, O. and Tang, Y.-S. (1993) Identification of endogenouselectrophiles by means of mass spectrometric determination of protein andDNA adducts. Environ. Health Perspect., 99, 19-24
19. van Ddft, J.H.M., van Winden, M.J.M., van den Ende, A.M.C. and Baan, R.A.(1993) Determining A^-alkylguanine adducts by immunochemical methodsand HPLC with electrochemical detection: Applications in animal studies andin monitoring human exposure to alkylating agents. Environ. Health Perspect., 99, 25-32
20. Shuker, D.E.G., Prevost, V., Friesen, M.D., Lin, D., Ohshima, H. and Bartsch, H. (1993) Urinary markers for measuring exposure to endogenousand exogenous alkylating agents and precursors. Environ. Health Perspect., 99, 33-37
21. Groopman, J.D., Wild, C.P., Hasler, J., Junshi, C., Wogan, G.N. andKensler, T.W. (1993) Molecular epidemiology of aflatoxin exposures:validation of aflatoxin-N1-guanine levels in urine as a biomarker inexperimental rat models and humans. Environ. Health Perspect., 99, 107-113
22. Mustonen, R., F6rsti, A., Hietanen, P. and Hemminki, K. (1991) Measurementby 32P-postlabelling of 7-methylguanine levels in white blood cell DNA ofhealthy individuals and cancer patients treated with dacarbazine andprocarbazine. Human data and method development for 7-alkylguanines.Carcinogenesis, 12, 1423-1431
23. Shields, P.G., Povey, A.C., Wilson, V.L., Weston, A. and Harris, C.C. (1990) Combined high-performance liquid chromatography/32P-postlabeling assayof lV7-methyldeoxyguanosine. Cancer Res., 50, 6580-6584
24. Wilson, V.L., Weston, A., Manchester, D.K., Trivers, G.E., Roberts, D.W., Kadlubar, F.F., Wild, C.P., Montesano, R., Willey, J.C., Mann, D.L. andHarris, C.C. (1989) Alkyl and aryl carcinogen adducts detected in humanperipheral lung. Carcinogenesis, 10, 2149-2153
25. Weston, A., Rowe, M.L., Manchester, D.K., Farmer, P.B., Mann, D.L. andHarris, C.C. (1989) Fluorescence and mass spectral evidence for the formationof benzo(a)pyrene anti-diol-epoxine-DNA and -hemoglobin adducts inhumans. Carcinogenesis, 10, 251-257
26. Fichtinger-Schepman, A.M.J., van Oosterom, A.T., Lohman, P.H.M. andBerends, F. (1987) ar-Diamminedichloroplatinum(II)-induced DNA adductsin peripheral leukocytes from seven cancer patients: quantitativeimmunochemical detection of the adduct induction and removal after a singledose of cis-diamminedichloroplatinum(II). Cancer Res., 47, 3000-3004
27. Souliotis, V.L., Kaila, S., Boussiotis, V.A., Pangahs, G.A. and Kyrtopoulos, S.A. (1990) Accumulation of 0-methylguanine in human blood leukocyte DNAduring exposure to procarbazine and its relationships with dose and repair.Cancer Res., 50, 2759-2764
28. Mustonen, R. and Hemminki, K. (1992) 7-Methylguanine levels in DNA ofsmokers’ and non-smokers’ total white blood cells, granulocytes andlymphocytes. Carcinogenesis, 13, 1951-1955
29. Mustonen, R., Schoket, B. and Hemminki, K. (1993) Smoking-related DNAadducts: ^P-postlabding analysis of 7-methylguanine in human bronchial andlymphocyte DNA. Carcinogenesis, 14, 151-154
30. Kato, S., Petruzelli, S., Bowman, E.D., Turteltaub, K.W., Blomeke, B., Weston, A. and Shields, P.G. (1993) 7-Alkyldeoxyguanosine adduct detectionby two-step HPLC and the 32P-posdabelling assay. Carcinogenesis, 14, 545-550
31. Singer, B. and Grunberger, D. (1983) Molecular Biology of Mutagens andCarcinogens. Plenum Press, New York
32. Hutchinson, F. (1989) Use of data from bacteria to interpret data on DNAdamage processing in mammalian cells. Mutat. Res., 220, 269-278
33. Dixon, K., Roilides, E., Hauser J. and Levine, A.S. (1989) Studies on direct and indirect effects of DNA damage on mutagenesis in monkey cells usingan SV40-based shuttle vector. Mutat. Res., 220, 73-82
34. Ingle, C.A. and Drinkwater, N.R. (1989) Mutational specificities of1'-acetoxysafrole, W-benzoyloxy-W-methyl-4-aminoazobenzene, and ethylmethanesulfonate in human cells. Mutat. Res., 220, 133-142
35. Maher, V.M., Yang, J.-L., Mah, C.-M. and McConnick, J.J. (1989) Comparingthe frequency and spectra of mutations induced when an SV-40 based shutdevector containing covalently bound residues of structurally-related carcinogensreplicates in human cells. Mutat. Res., 220, 83-92
36. Kat, A.G. and Thilly, W.G. (1993) Mutational spectra in mammalian cells.In HetnminlriJC., Dipple, A., Shuker, D.E.G., Kadlubar, F.F., Segerb8ck, D.and Bartsch, H. (eds), DNA Adducts: Identification and Biological Significance.IARC, Lyon, in press
37. Ieh man, T. A. and Harris, C.C. (1993) Mutational spectra of proto-oncogenes and tumour suppressor genes: clues in predicting cancer etiology. InHanmmki, K., Dipple, A., Shuker, D.E.G., Kadlubar, F.F., SegerbSck, D. andBartsch, H. (eds), DNA Adducts: Identification and Biological Significance.IARC, Lyon, in press
38. Bohr, V.A. (1993) Gene-specific DNA damage and repair. In Hemminki, K., Dipple, A., Shuker, D.E.G., Kadlubar, F.F., SegerbSck, D. and Bartsch, H.(eds), DNA Adducts: Identification and Biological Significance. IARC, Lyon, in press
39. Kress, S., Sutter, C., Strickland, P.T., Mukhtar, H., Schweitzer, J. and Schwarz, M. (1992) Carcinogen-specific mutational pattern in the p53 genein ultraviolet B radiation-induced squamous cell carcinomas of mouse skin.Cancer Res., 52, 6400-6403
40. Hollstein, M., Sidransky, D., Vogelstein, B. and Harris, C.C. (1991) p53mutations in human cancers. Science, 253, 49-53
41. Jego, N., Thomas, G. and Hamelin, R. (1993) Short direct repeats flankingdeletions, and duplicating insertions in p53 gene in human cancers. Oncogene, 8, 209-213
42. Segerbfick, D. (1983) Alkylation of DNA and haemoglobin in the mouse following exposure to ethene and ethene oxide. Chem. -Biol. Interactions, 45, 139-151
43. Segerbsck, D. (1985) In vivo dosimetry of some alkylating agents as a basisfor risk estimation. PhD thesis, University of Stockholm, Stockholm
44. Lutz, W.K. (1979) In vivo covalent binding of organic chemicals to DNA asa quantitative indicator in the process of chemical carcinogenesis. Mutat. Res., 65, 289-356
45. Lijinsky, W. (1988) Nucleic acid alkylation by A'-nitroso compounds relatedto organ-specific carcinogenesis. In Politzer, P.and Martin, F.J. (eds), BioactiveMolecules. Chemical Carcinogens, Activation Mechanisms, Structural andElectronic Factors, and Reactivity. Elsevier, Amsterdam, pp. 63-90
46. Beland, F.A., Fullerton, N.F., Kinouchi, T. and Poirier, M.C. (1988) DNAadducts formation during continuous feeding of 2-acetylaminofiuorene atmultiple concentrations. In Bartsch, H., Hemminki, K.and O’Neill, I.K. (eds), Methods for Detecting DNA Damaging Agents in Humans: Applications inCancer Epidemiology and Prevention. IARC, Lyon, pp. 175-180
47. Hemminki, K., F6rsti, A., Mustonen, R. and Savela, K. (1986) DNA adductsin experimental cancer research. J. Cancer. Res. din. Oncol, 112, 181-188
48. Beland, F.A. and Kadlubar, J.F. (1985) Formation and persistence of arylamineDNA adducts in vivo. Environ. Health Perspect., 62, 19-30
49. Swenberg, J.A., Dryoff, M.C., Bedell, M.A., Popp, J.A., Huh, N., Kirstein, U.and Rajewsky, M.F. (1984) (p-ethyldeoxyguanosine, but not O^-ethyldeoxy-guanosine, accumulates in hepatocyte DNA of rats exposed continuously todiethylnitrosamine. Proc. Natl Acad. Sci. USA, 81, 1692-1695
50. Swenberg, J.A., Richardson, F.C., Boucheron, J.A. and Dryoff, M.C. (1985) Relationships between DNA adduct formation and carcinogenesis. Environ.Health Perspect., 62, 177-183
51. Wogan, G.N. and Gorelick, N J. (1985) Chemical and biochemical dosimetryof exposure to genotoxk chemicals. Environ. Health Perspect., 62, 5-18
52. Poirier, M. and Beland, F.A. (1992) DNA adduct measurements in tumourincidence during chronic carcinogen exposure in animal models: Implicationsfor DNA adduct-based human cancer risk assessment Chem. Res. Taxicol., 5, 749-755
53. Croce, C.M. (1987) Role of chromosome translocations in human neoplasia.Cell, 49, 155-156
54. Knudson, A.G. (1985) Hereditary cancer, oncogenes, and antioncogenes.Cancer Res., 45, 1437-1443
55. Hansen, M.F. and Cavenee, W.K. (1987) Genetics of cancer predisposition.Cancer Res., 4, 1, 5518-5527
56. Bishop, JM. (1991) Molecular thanes in oncogenesis. Cell, 64, 235-248
57. Balmain, A. and Brown, K. (1988) Oncogene activation in chemicalcarcinogenesis. Adv. Cancer Res., 51, 147-182
58. Aaronson, S.A. (1991) Growth factors and cancer. Science, 254, 1146-1153
59. Peltomfild, P., Aaltonen, L.A., Sistonen, P., PylkkSnen, L., Mecldin, J.P., Srvinen, H., Green, J.S., Jass, J.R., Weber, J. L., Leach, FS., Petersen, G.M., Hamilton, S.R., de la Chapelle, A. and Vogelstein, B. (1993) Genetic mappingof a locus predisposing to human colorectal cancer. Science, 260, 810-812
60. Aaltonen, L. A., Peltomfiki, P., Leach, F.S., Sistonen, P., Pylkkfinen, L., Mecklin, J.-P., JSrvinen, H., Powell, S.M., Jen, J., Hamilton, S.R., Petersen, G.M., Kinzler, K.W., Vogelstein, B. and de la Chapelle, A. (1993)Clues to the pathogenesis of familial colorectal cancer. Science, 260, 812-816
61. Thibodeau, S.N., Bren, G. and Schaid, D. (1993) Microsatellite instability incancer of the proximal colon. Science, 260, 816-819
62. Levy, D.D., Groopman, J.D., Lim, S.E., Seidman, M.M. and Kraemer, K.H.(1992) Sequence specificity of aflatoxin Bl-induced mutations in a plasmidreplicated in xeroderma pigmentosum and DNA repair proficient human cells.Cancer Res., 52, 5668-5673
63. Reid, T.M. and Loeb, L.A. (1993) Tandem double CC -TT mutations areproduced by reactive oxygen species. Proc. Natl Acad. Sci. USA, 90, 3904-3907
64. Brash, D.E., Rudolph, J.A., Simon, J.A., Lin, A., McKenna, GJ, Baden, H.P., Hal perm, A.J.and Pontdn, J. (1991) A role for sunlight in skin cancer UV-induced p53 mutations in squamous cell carcinoma. Proc. Natl Acad. Sci.USA, 88, 10124-10128
65. Ziegler, A., Leffe, U.D.J., Kunala, S., Sharma, H.W., Gailani, M., Simon, J.A., Halperin, A.J., Baden, H.P., Shapiro, P.E., Bale, A.E. and Brash, D.E. (1993)Mutation hotspots due to sunlight in the p53 gene of nonmelanoma skin cancer.Proc. Natl Acad. Sci. USA, 90, 4216-4220
66. Molds, I.P., Moyret, C., Guillot, B., Jeanleur, P., Guilhou, J.-J., Theillet, C.and Basset-Seguin, N. (1993) p53 gene mutations in human epithelial skincancers. Oncogene, 8, 583-588
67. Nakazawa, H., English, D., Randell, P.L., Nakazawa, K., Martel, N., Armstrong, B.K. and Yamasaki, H. (1993) UV and skin cancer; specific p53gene mutation in normal skin as a biologically relevant exposure measurement.Proc. Natl Acad. Sd. USA, in press